The FINANCIAL — Janssen Pharmaceuticals announced the U.S. Food and Drug Administration has approved XARELTO, an oral anticoagulant, for the treatment of deep vein thrombosis and/or pulmonary embolism ...
NEW YORK (AP) — Johnson & Johnson’s Xarelto received an expanded indication as the Food and Drug Administration on Friday approved the blood thinner both to treat and to reduce the risk of recurrence ...
Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...
The EINSTEIN-PE Investigators. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. New England Journal of Medicine. (April 5, 2012) 366;14. The traditional treatment for patients ...
FRANKFURT, May 28 (Reuters) - Bayer AG said it has submitted anti-clotting drug Xarelto for marketing authorisation in Japan for the treatment of deep vein thrombosis and pulmonary embolism, the ...
Xarelto is a brand-name prescription medication approved to treat or help prevent harmful blood clots in certain adults and children. A program called the Xarelto withMe Savings Card may be available ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using RIVAROXABAN-TEVA? RIVAROXABAN-TEVA contains the ...
Across the RE‑COVER trials, 9 patients (0.4%) in the dabigatran arms and 5 (0.2%) in the warfarin arms had an acute coronary syndrome event. Of these, 8 patients (0.3%) in the dabigatran arms and 4 (0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback